Screener
The Cooper Companies, Inc. COO CooperSurgical — Cost of Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by The Cooper Companies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: The Cooper Companies, Inc.’s 10-Q, filed June 5, 2026.
- Filed
- Jun 5, 2026, 4:47 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-041305
| (In millions) / Three Months Ended April 30, 2026 | Cooper Vision | Cooper Surgical | Corporate (1) | Consolidated |
|---|---|---|---|---|
| Net sales | $723.5 | $358.0 | — | $1,081.5 |
| Cost of sales | 229.4 | 116.7 | — | 346.1 |
| Selling, general and administrative expense | 252.2 | 402.4 | 21.6 | 676.2 |
| Research and development expense | 22.1 | 20.4 | — | 42.5 |
| Amortization expense | 4.2 | 43.5 | — | 47.7 |
| Operating income (loss) | $215.6 | $(225.0) | $(21.6) | $(31.0) |
| Interest expense | 20.9 | |||
| Other (income) expense, net | (3.5) |
Item 1. Unaudited Financial Statements
FAQ
- What is The Cooper Companies, Inc.'s coopersurgical — cost of sales?
- The Cooper Companies, Inc. (COO) reported coopersurgical — cost of sales of $116.7M in Q1 2026.
- How has The Cooper Companies, Inc.'s coopersurgical — cost of sales changed year-over-year?
- The Cooper Companies, Inc.'s coopersurgical — cost of sales increased by 8.5% year-over-year, from $107.6M to $116.7M.
- What does coopersurgical — cost of sales mean?
- Represents the direct costs attributable to the production of medical devices and surgical products within the CooperSurgical segment. This includes raw materials, direct labor, and manufacturing overheads required to bring products to a saleable condition.
Ask your AI about The Cooper Companies, Inc.'s coopersurgical — cost of sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude